XNAS 23 Jan, 2026 4:30 PM (EST)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Eli M. Wallace | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2026 | 1,114,400 | 1,114,400 | - | - | Stock Option (Right to Buy) | |
| Eli M. Wallace | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Dec 2025 | 1,114,400 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Eli M. Wallace | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2025 | 1,614,400 | 1,614,400 | - | - | Stock Option (Right to Buy) | |
| Yong Ben | Chief Med & Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 357,177 | 357,177 | - | - | Stock Option (Right to Buy) | |
| Eli M. Wallace | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 499,731 | 499,731 | - | - | Stock Option (Right to Buy) | |
| Jacob Bauer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 138,193 | 138,193 | - | - | Stock Option (Right to Buy) | |
| Pedro J. Beltran | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 357,177 | 357,177 | - | - | Stock Option (Right to Buy) | |
| Frank P. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 91,076 | 91,076 | - | - | Stock Option (Right to Buy) | |
| Bihua Chen | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 4,172,126 | 0 | - | - | Class B ordinary shares | |
| Bihua Chen | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Aug 2025 | 4,172,126 | 4,681,126 | - | - | Common Stock | |
| Bihua Chen | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Aug 2025 | 307,874 | 4,172,126 | - | - | Class B ordinary shares | |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 284,571 | 5,952,356 | - | - | Common Stock | |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 1,762,760 | 3,305,470 | - | - | Common Stock | |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2025 | 1,905,046 | 1,905,046 | - | - | Common Stock | |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 5,598,425 | 5,667,785 | - | 10.7 | 60,000,000 | Common Stock |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 639,110 | 1,542,710 | - | 10.7 | 6,849,534 | Common Stock |
| Bihua Chen | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.72 per share. | 11 Aug 2025 | 760,496 | 2,187,536 | - | 10.7 | 8,150,464 | Common Stock |
| Bihua Chen | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Aug 2025 | 152,940 | 4,528,186 | - | 0 | Common Stock |